MDCO

The Medicines Company Press Releases

$33.3
*  
0.54
1.65%
Get MDCO Alerts
*Delayed - data as of Jul. 7, 2015  -  Find a broker to begin trading MDCO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Federal Circuit Rules Against The Medicines Company in Angiomax® (bivalirudin) Patent Litigation
7/2/2015 12:34:00 PM - Business Wire
▲11.00 % Price Change since this news event. The Volume Ratio is 4.13.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


The Medicines Company Announces FDA Approval of KENGREAL™ (cangrelor) as an Adjunct to Percutaneous Coronary Intervention (PCI) for Reducing Thrombotic Events
6/22/2015 3:02:00 PM - Business Wire
▲12.08 % Price Change since this news event. The Volume Ratio is 1.39.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


The Medicines Company to Hold Conference Call on Tuesday, June 2 to Discuss Clinical Trial Results of ABP-700 and MDCO-216
6/1/2015 7:00:00 AM - Business Wire
▲17.46 % Price Change since this news event. The Volume Ratio is 1.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




The Medicines Company Announces Results of Phase 1 Study for Novel Investigational Intravenous Anesthetic, ABP-700
6/1/2015 7:00:00 AM - Business Wire
▲17.46 % Price Change since this news event. The Volume Ratio is 1.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


The Medicines Company Presents New Data Showing Remodeling Effect of MDCO-216 on HDL Particles in Coronary Artery Disease Patients
5/26/2015 10:30:00 AM - Business Wire
▲23.56 % Price Change since this news event. The Volume Ratio is 0.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


The Medicines Company to participate in the Jefferies 2015 Healthcare Conference
5/22/2015 7:00:00 AM - Business Wire
▲21.18 % Price Change since this news event. The Volume Ratio is 1.1.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


















The Medicines Company Stock Trading Halted Today
4/15/2015 7:01:00 AM - Business Wire